13 Feb 2026 | 3 Mins Read
Natco Pharma shares drop due to USFDA Chennai unit issues
Flipitmoney
Natco Pharma shares declined over 2% as the US FDA issued seven observations under Form 483 for its Chennai API unit following an 11/17-21/2025 inspection, classifying the inspection as voluntary action indicated. The inspection occurred after the company reported a 14.3% net profit increase and 36.3% revenue rise.